PCSK9 and Hypercholesterolemia: The finding that CVD patients have higher plasma PCSK9 levels is in line with previous reports showing PCSK9 to be associated with the Framingham Risk Score [40] or with inflammation in the acute phase and hypercholesterolemia in patients with acute coronary syndrome [41].